Parsortix® PC1 Clinical System

The first FDA cleared medical device for the capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer patient blood for subsequent analysis.

Parsortix® PC1 Clinical System

We only use necessary cookies on our website.

Ok, I got it